WELL, GOOD: Study: Drug reduces inflammation in early stroke symptoms. “The body uses the protein Interleukin-1 to combat a range of illnesses but scientists at the University of Manchester have previously found that it increases inflammation and brain injury after a stroke. The drug anakinra, also known as IL-1Ra, blocks Interleukin-1 and prevents complications that make a stroke even more dangerous. In earlier research, the drug reduced inflammation in stroke and sub-arachnoid haemorrhage patients, and the Stroke Association funded the new study to focus on early onset of ischemic strokes.”